The major pathological type of non-small cell lung cancer is lung adenocarcinoma (LAC), which has a poor prognosis. BRCA1-associated protein-1 (BAP1) is a newly identified tumor suppressor that regulates a number of cellular functions in somatic malignancies. However, the impact of BAP1 expression in LAC has not been investigated.
Shen et al BMC Cancer (2016) 16:670 DOI 10.1186/s12885-016-2670-x RESEARCH ARTICLE Open Access BRCA1-associated protein deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion Chen Shen1,2,3†, Yiqin Wang4†, Ping Wei1,2,3 and Xiang Du1,2,3* Abstract Background: The major pathological type of non-small cell lung cancer is lung adenocarcinoma (LAC), which has a poor prognosis BRCA1-associated protein-1 (BAP1) is a newly identified tumor suppressor that regulates a number of cellular functions in somatic malignancies However, the impact of BAP1 expression in LAC has not been investigated Methods: A total of 112 cases of LAC and 101 cases of non-neoplastic lung diseases were included in this study The study focused on BAP1 expression in lung tissues and its relationship to patients’ clinical and pathological features BAP1 expression was detected by immunohistochemistry A human LAC cell line NCI-H1299 was transfected with lipofectamine p3xFLAG-BAP1 BAP1 gene expression was silenced in another LAC cell line NCI-H1650, in order to test the inhibitory effect of BAP1 on cell migration and invasion, as well as cell cycle regulation Results: BAP1 expression showed a negative correlation with tumorigenesis of LAC (p